标题
The amyloid-β peptide: Guilty as charged?
作者
关键词
-
出版物
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Volume -, Issue -, Pages 166945
出版商
Elsevier BV
发表日期
2023-11-06
DOI
10.1016/j.bbadis.2023.166945
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The amyloid precursor protein modulates the position and length of the axon initial segment
- (2023) Fulin Ma et al. JOURNAL OF NEUROSCIENCE
- Donanemab in Early Symptomatic Alzheimer Disease
- (2023) John R. Sims et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
- (2022) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome
- (2022) Elizabeth J. Andrews et al. Frontiers in Neuroscience
- Lecanemab in Early Alzheimer’s Disease
- (2022) Christopher H. van Dyck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
- (2021) Stephen Salloway et al. NATURE MEDICINE
- The case for low-level BACE1 inhibition for the prevention of Alzheimer disease
- (2021) Eric McDade et al. Nature Reviews Neurology
- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease
- (2019) Michael F. Egan et al. Alzheimers Research & Therapy
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
- (2019) Justin M. Long et al. CELL
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amyloid-Beta Solubility in the Treatment of Alzheimer’s Disease
- (2018) M. Paul Murphy NEW ENGLAND JOURNAL OF MEDICINE
- Postmortem Pittsburgh Compound B (PiB) Binding Increases with Alzheimer's Disease Progression
- (2018) Tina L. Beckett et al. JOURNAL OF ALZHEIMERS DISEASE
- The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the “amyloid cascade hypothesis”
- (2017) John Hardy FEBS Journal
- Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer’s Disease: The Role of APP
- (2017) Eric Doran et al. JOURNAL OF ALZHEIMERS DISEASE
- Not just amyloid: physiological functions of the amyloid precursor protein family
- (2017) Ulrike C. Müller et al. NATURE REVIEWS NEUROSCIENCE
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Alzheimer's Disease and the Amyloid-β Peptide
- (2017) M. Paul Murphy et al. JOURNAL OF ALZHEIMERS DISEASE
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
- (2015) Celeste M. Karch et al. BIOLOGICAL PSYCHIATRY
- Lessons from a Failed γ-Secretase Alzheimer Trial
- (2014) Bart De Strooper CELL
- Pittsburgh compound B and the postmortem diagnosis of alzheimer disease
- (2012) Dana M. Niedowicz et al. ANNALS OF NEUROLOGY
- BACE2 Expression Increases in Human Neurodegenerative Disease
- (2011) Christopher J. Holler et al. AMERICAN JOURNAL OF PATHOLOGY
- ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons
- (2010) Peer-Hendrik Kuhn et al. EMBO JOURNAL
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
- (2009) John Hardy JOURNAL OF NEUROCHEMISTRY
- BACE1 and BACE2 enzymatic activities in Alzheimer’s disease
- (2009) Rachel R. Ahmed et al. JOURNAL OF NEUROCHEMISTRY
- Oligomeric amyloid associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
- (2009) R. M. Koffie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain
- (2008) Joshua R. Steinerman et al. ARCHIVES OF NEUROLOGY
- Moving towards a vaccine
- (2008) David M. Holtzman NATURE
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started